Insider Trading activities of Depomed Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Depomed Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Depomed Inc since year 2005. Table 2 shows the detailed insider transactions of Depomed Inc since 2005. The reporting company's ticker symbol is DEPO. The reporting company's CIK number is 1005201.
The total value of stock buying since 2005 is $741,756.
The total value of stock sales since 2005 is $11,984,517.
The total value of stock option exercises since 2005 is $6,536,243.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Depomed Inc (DEPO).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-06 15,000 $148,800 202,387 $1,937,045 160,820 $1,048,546
2017-05 0 $0 109,212 $1,274,549 0 $0
2017-03 0 $0 0 $0 15,000 $49,050
2017-02 0 $0 0 $0 70,000 $206,500
2016-11 0 $0 5,000 $104,200 5,000 $63,450
2016-09 0 $0 11,250 $281,250 0 $0
2016-08 0 $0 31,290 $656,986 3,297 $41,838
2016-05 0 $0 35,000 $654,600 0 $0
2016-03 0 $0 33,000 $519,780 33,018 $195,206
2016-01 0 $0 0 $0 18,180 $129,441
2015-12 0 $0 15,000 $270,975 11,365 $65,640
2015-09 0 $0 0 $0 83,561 $504,132
2015-06 0 $0 5,000 $103,500 0 $0
2015-05 0 $0 0 $0 55,679 $375,157
2015-04 0 $0 0 $0 54,710 $236,730
2015-01 0 $0 0 $0 19,000 $95,570
2014-12 0 $0 22,405 $355,185 40,700 $340,252
2014-11 0 $0 71,000 $1,090,347 81,000 $488,470
2014-08 0 $0 0 $0 30,000 $183,300
2014-05 0 $0 0 $0 73,040 $281,063
2014-03 0 $0 102,744 $1,507,692 31,875 $118,393
2013-12 0 $0 35,271 $296,372 0 $0
2013-10 0 $0 0 $0 15,000 $97,500
2013-05 25,000 $127,625 0 $0 2,500 $13,375
2013-03 2,000 $11,920 0 $0 8,750 $16,012
2012-12 0 $0 113,370 $663,178 103,125 $251,156
2012-08 5,000 $25,040 0 $0 28,125 $46,368
2011-11 0 $0 0 $0 5,624 $15,972
2011-09 5,000 $28,420 0 $0 12,083 $34,315
2011-08 20,000 $102,760 0 $0 10,000 $58,000
2011-06 1,000 $8,228 35,768 $293,767 23,334 $62,301
2011-05 7,300 $59,121 222,813 $1,838,231 197,813 $724,182
2011-04 0 $0 0 $0 10,000 $34,000
2011-03 0 $0 0 $0 20,000 $68,000
2009-10 0 $0 0 $0 30,000 $98,250
2009-08 0 $0 27,724 $101,691 15,000 $29,700
2009-07 0 $0 0 $0 15,000 $43,125
2009-06 5,000 $13,425 0 $0 0 $0
2009-03 5,000 $10,000 0 $0 0 $0
2008-12 11,451 $17,199 0 $0 0 $0
2008-11 110,930 $168,338 0 $0 0 $0
2007-11 8,000 $20,880 0 $0 0 $0
2007-06 0 $0 0 $0 25,000 $131,250
2007-05 0 $0 8,085 $35,169 0 $0
2007-04 0 $0 0 $0 66,667 $200,001
2007-01 0 $0 0 $0 8,333 $24,999
2006-12 0 $0 0 $0 30,000 $90,000
2006-10 0 $0 0 $0 83,333 $74,999

Table 2. Detailed insider stock purchases, sales, and option exercises of Depomed Inc insiders (DEPO)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-06-13 Vargas Thadd M (SVP, Business Development) Sale 202,387 9.57 1,937,045
2017-06-13 Vargas Thadd M (SVP, Business Development) Option Ex 160,820 6.52 1,048,546
2017-06-12 Higgins Arthur J (President and CEO) Buy 15,000 9.92 148,800
2017-05-11 Vargas Thadd M (Senior VP, BD) Sale 50,000 12.03 601,250
2017-05-11 Gosling Matthew M (SVP, General Counsel) Sale 59,212 11.37 673,299
2017-03-31 Staple Peter D Option Ex 15,000 3.27 49,050
2017-02-21 Zenoff David B Option Ex 70,000 2.95 206,500
2016-11-14 Moretti August J (Chief Financial Officer & SVP) Sale 5,000 20.84 104,200
2016-11-14 Moretti August J (Chief Financial Officer & SVP) Option Ex 5,000 12.69 63,450
2016-09-21 Vargas Thadd M (Senior VP, BD) Sale 11,250 25.00 281,250
2016-08-10 Vargas Thadd M (Senior VP, BD) Sale 26,290 20.92 549,986
2016-08-10 Moretti August J (Chief Financial Officer & SVP) Sale 5,000 21.40 107,000
2016-08-10 Moretti August J (Chief Financial Officer & SVP) Option Ex 3,297 12.69 41,838
2016-05-23 Vargas Thadd M (Senior VP, BD) Sale 15,000 20.00 300,000
2016-05-10 Vargas Thadd M (Senior VP, BD) Sale 15,000 17.64 264,600
2016-05-09 Moretti August J (Chief Financial Officer & SVP) Sale 5,000 18.00 90,000
2016-03-18 Schoeneck James A (President and CEO) Option Ex 30,483 5.42 165,217
2016-03-11 Vargas Thadd M (Senior VP, BD) Sale 23,000 16.00 368,000
2016-03-08 Srinivas G. Rao (SVP and Chief Medical Officer) Option Ex 2,535 11.83 29,989
2016-03-02 Vargas Thadd M (SVP, Business Development) Sale 10,000 15.18 151,780
2016-01-11 Vargas Thadd M (SVP, Business Development) Option Ex 18,180 7.12 129,441
2015-12-28 Schoeneck James A (President and CEO) Option Ex 6,365 6.11 38,890
2015-12-16 Moretti August J (Chief Financial Officer & SVP) Option Ex 5,000 5.35 26,750
2015-12-03 Moretti August J (Chief Financial Officer & SVP) Sale 15,000 18.07 270,975
2015-09-30 Staple Peter D Option Ex 20,000 4.74 94,800
2015-09-29 Schoeneck James A (President and CEO) Option Ex 63,561 6.44 409,332
2015-06-12 Vargas Thadd M (Senior VP, BD) Sale 5,000 20.70 103,500
2015-05-12 Schoeneck James A (President and CEO) Option Ex 45,679 6.86 313,357
2015-05-12 Staple Peter D Option Ex 10,000 6.18 61,800
2015-04-08 Vargas Thadd M (Senior VP, BD) Option Ex 54,710 4.33 236,730
2015-01-20 Vargas Thadd M (Senior VP, BD) Option Ex 19,000 5.03 95,570
2014-12-19 Schoeneck James A (President and CEO) Option Ex 40,700 8.36 340,252
2014-12-02 Vargas Thadd M (Senior VP, BD) Sale 8,247 15.85 130,739
2014-12-02 Gosling Matthew M (Senior VP, General Counsel) Sale 8,819 15.85 139,807
2014-12-02 Moretti August J (Chief Financial Officer) Sale 5,339 15.85 84,639
2014-11-25 Staple Peter D Option Ex 10,000 5.04 50,400
2014-11-19 Gosling Matthew M (Senior VP, General Counsel) Sale 71,000 15.36 1,090,347
2014-11-19 Gosling Matthew M (Senior VP, General Counsel) Option Ex 71,000 6.17 438,070
2014-08-01 Schoeneck James A (President and CEO) Option Ex 30,000 6.11 183,300
2014-05-16 Vargas Thadd M (Senior VP, BD) Option Ex 39,040 3.09 120,633
2014-05-09 Schoeneck James A (President and CEO) Option Ex 30,000 4.53 135,750
2014-05-09 Gosling Matthew M (Senior VP, General Counsel) Option Ex 4,000 6.17 24,680
2014-03-14 Vargas Thadd M (Senior VP, BD) Sale 63,869 14.69 938,235
2014-03-14 Vargas Thadd M (Senior VP, BD) Option Ex 10,000 5.08 50,800
2014-03-14 Schoeneck James A (President and CEO) Sale 17,000 14.54 247,129
2014-03-14 Gosling Matthew M (Senior VP, General Counsel) Sale 21,875 14.73 322,328
2014-03-14 Gosling Matthew M (Senior VP, General Counsel) Option Ex 21,875 3.09 67,593
2013-12-02 Vargas Thadd M (Senior VP, BD) Sale 5,296 8.40 44,507
2013-12-02 Schoeneck James A (President and CEO) Sale 17,192 8.40 144,447
2013-12-02 Sweeney Michael Md (CMO and VP, R&D) Sale 4,270 8.40 35,876
2013-12-02 Gosling Matthew M (Senior VP, General Counsel) Sale 5,692 8.40 47,835
2013-12-02 Moretti August J (Chief Financial Officer) Sale 2,821 8.40 23,707
2013-10-15 Staple Peter D Option Ex 15,000 6.50 97,500
2013-05-17 Moretti August J (Chief Financial Officer) Option Ex 2,500 5.35 13,375
2013-05-10 Schoeneck James A (President and CEO) Buy 25,000 5.11 127,625
2013-03-06 Dawes Karen A Buy 2,000 5.96 11,920
2013-03-04 Vargas Thadd M (Senior VP, BD) Option Ex 8,750 1.83 16,012
2012-12-13 Sweeney Michael Md (CMO and VP, R&D) Sale 43,635 5.87 256,006
2012-12-13 Sweeney Michael Md (CMO and VP, R&D) Option Ex 40,000 1.83 73,200
2012-12-12 Gosling Matthew M (Senior VP, General Counsel) Sale 65,702 5.84 383,831
2012-12-12 Gosling Matthew M (Senior VP, General Counsel) Option Ex 48,125 3.09 148,706
2012-12-06 Sweeney Michael Md (CMO and VP, R&D) Sale 1,418 5.76 8,174
2012-12-06 Gosling Matthew M (Senior VP, General Counsel) Sale 2,615 5.80 15,167
2012-12-05 Stern Julian N Option Ex 15,000 1.95 29,250
2012-08-14 Staple Peter D Buy 5,000 5.01 25,040
2012-08-09 Vargas Thadd M (Senior VP, BD) Option Ex 13,125 1.83 24,018
2012-08-07 Schoeneck James A (President and CEO) Option Ex 15,000 1.49 22,350
2011-11-09 Vargas Thadd M (Senior VP, BD) Option Ex 5,624 2.84 15,972
2011-09-09 Staple Peter D Buy 5,000 5.68 28,420
2011-09-08 Vargas Thadd M (Senior VP, BD) Option Ex 12,083 2.84 34,315
2011-08-23 Schoeneck James A (President and CEO) Buy 20,000 5.14 102,760
2011-08-02 Stern Julian N Option Ex 10,000 5.80 58,000
2011-06-15 Sweeney Michael Md (CMO and VP, R&D) Sale 1,385 8.39 11,627
2011-06-14 Sweeney Michael Md (CMO and VP, R&D) Sale 4,470 8.18 36,555
2011-06-14 Cameron Tammy (VP, Finance) Sale 29,913 8.21 245,585
2011-06-14 Cameron Tammy (VP, Finance) Option Ex 23,334 2.67 62,301
2011-06-14 Dawes Karen A Buy 1,000 8.23 8,228
2011-05-16 Zenoff David B Buy 2,300 8.02 18,446
2011-05-13 Staple Peter D Buy 2,500 7.97 19,925
2011-05-13 Burrill Steven Sale 69,250 8.09 560,024
2011-05-13 Burrill Steven Option Ex 69,250 3.88 268,828
2011-05-12 Cameron Tammy (VP, Finance) Sale 18,821 8.26 155,367
2011-05-12 Cameron Tammy (VP, Finance) Option Ex 18,821 1.83 34,442
2011-05-12 Staple Peter D Buy 2,500 8.30 20,750
2011-05-12 Burrill Steven Sale 87,000 8.25 717,750
2011-05-12 Burrill Steven Option Ex 62,000 5.32 329,964
2011-05-11 Cameron Tammy (VP, Finance) Sale 47,742 8.48 405,090
2011-05-11 Cameron Tammy (VP, Finance) Option Ex 47,742 1.91 90,948
2011-04-04 Burrill Steven Option Ex 10,000 3.40 34,000
2011-03-03 Stern Julian N Option Ex 20,000 3.40 68,000
2009-10-21 Stern Julian N Option Ex 30,000 3.27 98,250
2009-08-11 Gosling Matthew M (VP, General Counsel) Sale 27,724 3.67 101,691
2009-08-11 Gosling Matthew M (VP, General Counsel) Option Ex 15,000 1.98 29,700
2009-07-10 Burrill Steven Option Ex 15,000 2.88 43,125
2009-06-15 Staple Peter D Buy 5,000 2.69 13,425
2009-03-11 Staple Peter D Buy 5,000 2.00 10,000
2008-12-11 Zenoff David B Buy 6,451 1.55 9,999
2008-12-01 Dawes Karen A Buy 5,000 1.44 7,200
2008-11-26 Burrill Steven Buy 40,000 1.53 61,240
2008-11-25 Stern Julian N Buy 50,000 1.50 74,552
2007-11-06 Zenoff David B Buy 8,000 2.61 20,880
2007-06-12 Hamilton John F (VP & CFO) Option Ex 25,000 5.25 131,250
2007-05-31 Shell John N (VP, Operations) Sale 8,085 4.35 35,169
2007-04-10 Fara John W (President & CEO) Option Ex 66,667 3.00 200,001
2007-01-16 Shell John N (VP, Operations) Option Ex 8,333 3.00 24,999
2006-12-21 Hamilton John F (VP & CFO) Option Ex 30,000 3.00 90,000
2006-10-02 Fara John W (President & CEO) Option Ex 83,333 .90 74,999

Insider trading activities including stock purchases, stock sales, and option exercises of DEPO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Depomed Inc (symbol DEPO, CIK number 1005201) see the Securities and Exchange Commission (SEC) website.